Another independent biotech is acquired as Merck buys Cubist for $9.5B
December 08, 2014 at 11:18 AM EST
Merck & Co. pending's acquisition of Cubist Pharmaceuticals for $9.5 billion is a win for the Lexington company and for the antibiotics field as a whole...
